Pacira BioSciences PCRX reported its Q2 earnings results on Wednesday, August 3, 2022.
Here's what investors need to know about the announcement.
Pacira BioSciences missed estimated earnings by 42.05%, reporting an EPS of $0.51 versus an estimate of $0.88.
Revenue was up $33.82 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19 which was followed by a 6.75% drop in the share price the next day.
Here's a look at Pacira BioSciences's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.